Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.
The 21-kD protein Ras of the low-molecular-weight GTP-binding (LMWG) family plays an important role in transduction of extracellular signals. Ras functions as a 'molecular switch' in transduction of signals from the membrane receptors of many growth factors, cytokines, and other second messengers to the cell nucleus. Numerous studies have shown that in multiple malignant tumors and hematopoietic malignancies, faulty signal transduction via the Ras pathway plays a key role in tumorigenesis. In this work, a non-radioactive assay was used to quantify Ras activity in hematologic malignancies. Ras activation was measured in six different cell lines and 24 patient samples, and sequence analysis of N- and K-ras was performed. The 24 patient samples comprised of seven acute myelogenous leukemia (AML) samples, five acute lymphocytic leukemia (ALL) samples, four myeloproliferative disease (MPD) samples, four lymphoma samples, four juvenile myelomonocytic leukemia (JMML) samples, and WBC from a healthy donor. The purpose of this study was to compare Ras activity determined by percentage of Ras-GTP with the mutational status of the Ras gene in the hematopoietic cells of the patients. Mutation analysis revealed ras mutations in two of the seven AML samples, one in codon 12 and one in codon 61; ras mutations were also found in two of the four JMML samples, and in one of the four lymphoma samples (codon 12). We found a mean Ras activation of 23.1% in cell lines with known constitutively activating ras mutations, which was significantly different from cell lines with ras wildtype sequence (Ras activation of 4.8%). Two of the five activating ras mutations in the patient samples correlated with increased Ras activation. In the other three samples, Ras was probably activated through "upstream" or "downstream" mechanisms.
Raepple
D
D
Department of Medicine I, University of Freiburg Medical Center, Hugstetter Str. 55, 79106 Freiburg, Germany.
von Lintig
F
F
Zemojtel
T
T
Duchniewicz
M
M
Jung
A
A
Lübbert
M
M
Boss
G R
GR
Scheele
J S
JS
D004252:DNA Mutational Analysis; D006153:Guanosine Diphosphate / Q000032:analysis; D006160:Guanosine Triphosphate / Q000032:analysis; D019337:Hematologic Neoplasms / Q000737:chemistry* / Q000209:etiology / Q000235:genetics*; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D054429:Leukemia, Myelomonocytic, Juvenile; D008223:Lymphoma; D009154:Mutation; D009196:Myeloproliferative Disorders; D009857:Oncogenes; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D015398:Signal Transduction / Q000235:genetics; D014407:Tumor Cells, Cultured; D018631:ras Proteins / Q000032:analysis* / Q000235:genetics*
D006153:Guanosine Diphosphate; D006160:Guanosine Triphosphate; D018631:ras Proteins
Chin Med J (Engl). 1998 Apr;111(4):343-5
10374400
Cell Mol Life Sci. 2000 Dec;57(13-14):1950-63
11215520
Clin Cancer Res. 2000 May;6(5):1804-10
10815901
Growth Factors. 2005 Jun;23(2):143-9
16019436
Leukemia. 1998 Jun;12(6):887-92
9639416
Leukemia. 2004 Mar;18(3):466-75
14737077
Cell. 1990 Aug 10;62(3):599-608
2116237
Br J Haematol. 1991 Mar;77(3):323-7
2012756
Blood. 2005 Sep 15;106(6):2183-5
15928039
Mol Cell Biol. 1996 Aug;16(8):4107-16
8754809
Cell. 1997 Feb 7;88(3):333-46
9039260
Blood. 1994 Nov 15;84(10):3435-9
7949098
Nat Genet. 2007 Aug;39(8):1007-12
17603483
Nat Genet. 2003 Jun;34(2):148-50
12717436
J Exp Med. 1994 Jun 1;179(6):1855-65
8195713
Mol Med. 2000 Aug;6(8):693-704
11055588
Cell. 1992 Apr 17;69(2):265-73
1568246
Leukemia. 1990 Jul;4(7):486-9
2142747
N Engl J Med. 1997 Jun 12;336(24):1713-20
9180088
J Exp Med. 1995 Jan 1;181(1):307-13
7807010
Blood. 1999 May 1;93(9):3074-80
10216104
J Immunol. 1996 Oct 1;157(7):2844-50
8816388
Cell. 1994 Apr 22;77(2):307-16
8168137
Blood. 1994 Apr 15;83(8):2248-54
8161790
Proc Natl Acad Sci U S A. 1984 Jul;81(13):4008-12
6330729
Leuk Res. 1998 Nov;22(11):1003-7
9783802
Cancer. 2007 Nov 1;110(9):2000-6
17849425
Br J Haematol. 1995 Apr;89(4):905-7
7772531
Oncogene. 1987 May;1(2):157-65
3325880
Nat Genet. 2007 Aug;39(8):1013-7
17603482
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1097-100
7862641
Mol Reprod Dev. 1997 Jan;46(1):96-103
8981370
Science. 2007 Oct 19;318(5849):463-7
17947584
Blood. 1995 Nov 1;86(9):3517-21
7579458
Blood. 2001 Mar 1;97(5):1399-403
11222386